Trial
NCT06723171
Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Io Therapeutics
Collaborators
—
Condition
Psoriasis
Intervention
IRX4204
Why stopped
Sponsor request for study hold
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-03